Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Samantha Siva et al.|New England Journal of Medicine|2016Cited by 768
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|Obstetrical & Gynecological Survey|2016Cited by 373
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Kenneth Ngure, Connie Celum et al.|The Lancet HIV|2023Cited by 62
Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort studyLisa Noguchi, Jeanne Marrazzo, Barbra A. Richardson et al.|The Lancet HIV|2015Cited by 52
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort StudyKathryn Peebles, Felix Mhlanga, Flavia Matovu Kiweewa et al.|Clinical Infectious Diseases|2020Cited by 44